Capital Flow Monitor · Sponsors · CIK 2131355
Apogem GP-Led Fund 2026, LP
299 PARK AVENUE, NEW YORK, NY, 10171 · 212-601-3600
Pooled Investment Fund / Private Equity Fund · Limited Partnership· inc. DELAWARE true 2026
Fit score
—
Offering
—
Sold
$200.0M
% sold
—
Investors
2
Min investment
$1.0M
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-07-30 | D/A ·current | 506(b) | — | $200.0M | — | 2 | EDGAR ↗ |
| 2026-06-24 | D | 506(b) | — | $0 | — | 0 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed.
- N/A AGF 2026 GP, LLC — Director, New York, NY
- John M. Grady — Executive Officer, New York, NY
- Christopher M. Stringer — Executive Officer, RICHMOND, VA
- N/A Apogem Capital LLC — Promoter, New York, NY
- Michael Zeleniuch — Executive Officer, CHICAGO, IL
- Michael Greich — Executive Officer, CLEVELAND, OH
Placement agents
- Ny Life Distributors Llc · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.